Trial Profile
Single centre, Open-label trial of subcutaneous immunoglobulin in patients with multifocal motor neuropathy as maintenance therapy
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Jun 2015
Price :
$35
*
At a glance
- Drugs Immune globulin (Primary)
- Indications Multifocal motor neuropathy
- Focus Therapeutic Use
- 08 Jun 2015 New trial record
- 25 Apr 2015 Results presented at the 67th Annual Meeting of the American Academy of Neurology.